z-logo
open-access-imgOpen Access
At1 receptor blockers improve endothelial function (EF) and fibrinolytic activity (FA) in hypertensive patients with initial target organ damage
Author(s) -
M CAMPANELLA
Publication year - 2004
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1016/j.amjhyper.2004.03.161
Subject(s) - medicine , microalbuminuria , valsartan , endocrinology , plasminogen activator , endothelial dysfunction , tissue plasminogen activator , diabetes mellitus , heart failure , von willebrand factor , cardiology , plasminogen activator inhibitor 1 , fibrinolysis , angiotensin ii receptor type 1 , gastroenterology , blood pressure , angiotensin ii , platelet

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom